Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paltusotine in Subjects With Non-pharmacologically Treated Acromegaly
NCT05192382Phase 3Terminated
- Sponsor
- Crinetics Pharmaceuticals
- Start
- Dec 2021
- Primary completion
- Jan 2024
- Modality
- Small Molecules
- Countries
- 15
01
Overview
A Phase 3 trial of paltusotine in acromegaly, sponsored by Crinetics Pharmaceuticals. Started Dec 2021; status: terminated.
02
Drugs
paltusotine
03
Conditions
acromegaly
Beyond the preview
Go deeper on NCT05192382.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05192382.